TABLE 5.
Bacteriologic response by pathogen for patients evaluated for clinical efficacya
| Pathogen | No. of patients in the following group with the indicated responseb:
|
||
|---|---|---|---|
| Cefepime group (n = 32), eradication | Ceftriaxone group (n = 39)
|
||
| Eradication | Persistence | ||
| Enterobacter cloacae | 1 | ||
| Escherichia coli | 3 | 2 | |
| Haemophilus influenzae | 9 | 9 | |
| Haemophilus parahemolyticus | 1 | 3 | |
| Haemophilus parainfluenzae | 1 | 3 | |
| Haemophilus species | 1 | 1 | |
| Klebsiella pneumonia | 1 | ||
| Lactobacillus species | 1 | ||
| Pseudomonas aeruginosa | 1 | ||
| Pseudomonas fluorescens | 1 | 1 | |
| Staphylococcus aureus | 6 | 6 | |
| Streptococcus (β-hemolytic) | 2 | ||
| Streptococcus faecalis | 1 | ||
| Streptococcus (group C) | 1 | ||
| Streptococcus pneumoniae | 7 | 9 | |
a
Multiple pathogens may have been from the same patient.
b
No organisms persisted in the cefepime group. Eradication was documented or presumed.